Caspofungin Acetate for Injection Market

Caspofungin acetate for injection is an echinocandin antifungal indicated in adults and pediatric patients (3 months of age and older) for:

? Empirical therapy for presumed fungal infections in febrile, neutropenic patients.

? Treatment of candidemia and the following Candida infections: intra-abdominal abscesses, peritonitis and pleural space infections.

? Treatment of esophageal candidiasis.

? Treatment of invasive aspergillosis in patients who are refractory to or intolerant of other therapies.

Caspofungin Acetate for Injection Market contains market size and forecasts of Caspofungin Acetate for Injection in global, including the following market information:

Global Caspofungin Acetate for Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Caspofungin Acetate for Injection Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Caspofungin Acetate for Injection companies in 2021 (%)

The global Caspofungin Acetate for Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

50 mg (base)/Vial Injection Product Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Caspofungin Acetate for Injection include Merck Sharp & Dohme Ltd, Hengrui Pharma and Mylan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Caspofungin Acetate for Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Caspofungin Acetate for Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Caspofungin Acetate for Injection Market Segment Percentages, by Type, 2021 (%)

50 mg (base)/Vial Injection Product

70 mg (base)/Vial Injection Product

Others

Global Caspofungin Acetate for Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Caspofungin Acetate for Injection Market Segment Percentages, by Application, 2021 (%)

Adults Patients

Pediatric Patients

Global Caspofungin Acetate for Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Caspofungin Acetate for Injection Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Caspofungin Acetate for Injection revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Caspofungin Acetate for Injection revenues share in global market, 2021 (%)

Key companies Caspofungin Acetate for Injection sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Caspofungin Acetate for Injection sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Merck Sharp & Dohme Ltd

Hengrui Pharma

Mylan